BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weppler AM, Pattison A, Bhave P, De Ieso P, Raleigh J, Hatzimihalis A, Gill AJ, Balachander S, Callahan J, Chua M, Au-Yeung G, McArthur GA, Hicks RJ, Tothill RW, Sandhu S. Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma. J Immunother Cancer 2020;8:e000700. [PMID: 33060145 DOI: 10.1136/jitc-2020-000700] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Fine GC, Covington MF, Koppula BR, Salem AE, Wiggins RH, Hoffman JM, Morton KA. PET-CT in Clinical Adult Oncology-VI. Primary Cutaneous Cancer, Sarcomas and Neuroendocrine Tumors. Cancers (Basel) 2022;14:2835. [PMID: 35740501 DOI: 10.3390/cancers14122835] [Reference Citation Analysis]
2 Kang Z, Wang J, Huang W, Liu J, Yan W. Identification of Transcriptional Heterogeneity and Construction of a Prognostic Model for Melanoma Based on Single-Cell and Bulk Transcriptome Analysis. Front Cell Dev Biol 2022;10:874429. [DOI: 10.3389/fcell.2022.874429] [Reference Citation Analysis]
3 Ekmekci S, Lebe B. Biomarkers in Skin Carcinomas. Biomarkers in Carcinoma of Unknown Primary 2022. [DOI: 10.1007/978-3-030-84432-5_3] [Reference Citation Analysis]
4 Dall'Olio FG, Marabelle A, Caramella C, Garcia C, Aldea M, Chaput N, Robert C, Besse B. Tumour burden and efficacy of immune-checkpoint inhibitors. Nat Rev Clin Oncol 2021. [PMID: 34642484 DOI: 10.1038/s41571-021-00564-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 22.0] [Reference Citation Analysis]
5 Gehrcken L, Sauerer T, Schaft N, Dörrie J. T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options. Int J Mol Sci 2021;22:8679. [PMID: 34445385 DOI: 10.3390/ijms22168679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hasmat S, Howle JR, Karikios DJ, Carlino MS, Veness MJ. Immunotherapy in advanced Merkel cell carcinoma: Sydney west cancer network experience. J Med Imaging Radiat Oncol 2021. [PMID: 34053196 DOI: 10.1111/1754-9485.13243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]